Nu Skin Enterprises

Nu Skin Enterprises, Inc. is a holding company, which engages in the development and distribution of personal care products and nutritional supplements. It operates through the following segments: Mainland China, Americas, South Korea, Southeast Asia/Pacific, EMEA, Japan, Hong Kong/Taiwan, Nu Skin Other, Manufacturing, Grow Tech, and Rhyz Other. The first seven segments represent the Nu Skin geographic operations. The last three segments deal with Rhyz investments. Its brands include Nu Skin and Pharmanex. The company was founded by Blake M. Roney, Sandra N. Tillotson, and Steven J. Lund in 1984 and is headquartered in Provo, UT.

Earnings data Q2 2023

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Nu Skin Enterprises, Inc. is a holding company, which engages in the development and distribution of beauty and wellness solutions. It operates through the following segments: Mainland China, Americas, South Korea, Southeast Asia/Pacific, EMEA, Japan, Hong Kong/Taiwan, Nu Skin Other, Manufacturing, and Rhyz Other. The company was founded by Blake M. Roney, Sandra N. Tillotson, and Steven J. Lund in 1984 and is headquartered in Provo, UT.

Nu Skin Enterprises, Inc. (NUS) CEO Ritch Wood on Q4 2019 Results - Earnings Call Transcript

Nu Skin (NUS) delivered earnings and revenue surprises of 0.00% and 0.02%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

Nu Skin Enterprises (NUS) Q4 Earnings Match Estimates

Nu Skin Enterprises Inc. NUS, +3.38% shares dropped in the extended session Wednesday after the maker of supplements and personal care products blamed its disappointing outlook on sales in China due to the COVAD-19 coronavirus.

Nu Skin stock drops more than 10% on China profit warning

Impacts from foreign currency headwinds are likely to get reflected in Nu Skin's (NUS) fourth-quarter 2019 results. However, the company is on track with product launches and programs to bolster sales leaders.

Here's How Nu Skin (NUS) is Placed Ahead of Q4 Earnings

Nu Skin (NUS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Earnings Preview: Nu Skin Enterprises (NUS) Q4 Earnings Expected to Decline

If You're OK With Taking On Regulatory Risks, Nu Skin Might Be Right For You

Nu Skin (NUS) reported earnings 30 days ago. What's next for the stock?

Why Is Nu Skin (NUS) Down 4.4% Since Last Earnings Report?

Nu Skin (NUS) is battling headwinds in Mainland China thanks to increased scrutiny by the government. Also, management provides an unimpressive view for 2019.

Nu Skin Plunges in 6 Months, Mainland China Woes Persist

Nu Skin's (NUS) third-quarter earnings are affected by limited sales meetings in Mainland China.

Nu Skin's (NUS) Q3 Earnings Beat Estimates, Revenues Miss

Nu Skin Enterprises, Inc. (NUS) CEO Ritch Wood on Q3 2019 Results - Earnings Call Transcript

Nu Skin (NUS) delivered earnings and revenue surprises of 3.95% and -2.57%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

Nu Skin Enterprises (NUS) Tops Q3 Earnings Estimates

Shares of Nu Skin Enterprises Inc. NUS, -0.71% fell more than 7% in the extended session Tuesday after the maker of supplements and personal care products reported third-quarter earnings above expectations but sales missed the mark.

Nu Skin misses Q3 sales views, pins it on China weakness

Nu Skin's (NUS) third-quarter 2019 results are expected to reflect impacts of foreign currency headwinds.

Here's How Nu Skin (NUS) Looks Just Ahead of Q3 Earnings

Inter Parfums

NUS vs. IPAR: Which Stock Is the Better Value Option?

NUS vs. IPAR: Which Stock Should Value Investors Buy Now?

Nu Skin (NUS) is battling headwinds in Mainland China that led to an unimpressive view for 2019. However, a rising customer base bodes well.

Nu Skin's Customer Base Bodes Well, Mainland China is a Worry

Nu Skin (NUS) is battling headwinds in Mainland China, stemming from the government's campaign to scrutinize offerings of direct selling and health products industries.

Nu Skin Down 12% in 3 Months, Mainland China is a Concern

Nu Skin (NUS) Up 1.3% Since Last Earnings Report: Can It Continue?

Headwinds in Mainland China were a drag on Nu Skin's (NUS) revenues and earnings in the second quarter of 2019.

Nu Skin (NUS) Q2 Earnings In Line With Estimates, Sales Miss

Nu Skin Enterprises, Inc. (NUS) CEO Ritch Wood on Q2 2019 Results - Earnings Call Transcript

Nu Skin (NUS) delivered earnings and revenue surprises of 0.00% and -1.53%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

Nu Skin Enterprises (NUS) Meets Q2 Earnings Estimates

Nu Skin's (NUS) Q2 performance is likely to be hurt by the government campaign in Mainland China to inspect offerings of direct selling industries and health products.

Is a Disappointment in Store for Nu Skin (NUS) Q2 Earnings?

NUS or IPAR: Which Is the Better Value Stock Right Now?

The multilevel marketing company just reduced its full-year outlook. Here's why.

Why Nu Skin Enterprises Stock Dropped Today

LM Ericsson Telefon

Textron

These stocks helped contribute to the broader market's losses.

Why Textron, Nu Skin Enterprises, and Ericsson Slumped Today

Nu Skin Enterprises, Inc. (NYSE: NUS) shares are in free fall mode after reporting weak preliminary second-quarter earnings guidance.

News for Nu Skin Enterprises Stock (NUS)